Announcements Trials
Browse Landscape

Status

Completed 8Unknown 4Recruiting 3Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Observational 3

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 1780Neoplasms 1500Carcinoma, Non-Small-Cell Lung 1045Prostatic Neoplasms 958Colorectal Neoplasms 882Lung Neoplasms 803Pancreatic Neoplasms 573Carcinoma, Hepatocellular 543Leukemia, Myeloid, Acute 541Stomach Neoplasms 513Ovarian Neoplasms 508Neoplasm Metastasis 499Multiple Myeloma 494Recurrence 412Melanoma 387Squamous Cell Carcinoma of Head and Neck 370Brain Neoplasms 362Uterine Cervical Neoplasms 361Head and Neck Neoplasms 356Esophageal Neoplasms 312Precursor Cell Lymphoblastic Leukemia-Lymphoma 310Lymphoma 306Endometrial Neoplasms 305Triple Negative Breast Neoplasms 299Glioblastoma 299Rectal Neoplasms 282Sarcoma 266Urinary Bladder Neoplasms 264Hematologic Neoplasms 264Colonic Neoplasms 255

Interventions

relugolix 1Observation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Pregnancy Complications × Clear all
NCT07263490 2026-04-13

PRIOR

Copenhagen University Hospital, Hvidovre

Recruiting
462 enrolled
Lymphoid

Abruptio Placentae, Fetal Growth Retardation, Postpartum Hemorrhage, Obstetric Labor, Premature, Lymphoma, Follicular, Pre-Eclampsia, Pregnancy Complications, Diabetes, Gestational, Hypertension, Pregnancy-Induced

NCT05739123 2025-08-19

Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring

Sumitomo Pharma Switzerland GmbH

Recruiting
728 enrolled

Endometriosis, Leiomyoma, Pregnancy Complications

NCT06545994 2024-08-14

A Prospective Cohort Study on the Serum Kisspeptin Levels Throughout Pregnancy in PCOS

Fudan University

Recruiting
180 enrolled

Insulin Resistance, Polycystic Ovary Syndrome, Pregnancy Complications, Diabetes, Gestational

Data powered by HemOnc (CC BY 4.0) Colophon âš¡